Patient Characteristics and Treatment Before BMT
| Patient No. . | Age at Onset/Sex . | CNS Involvement . | Treatment Before BMT . | Clinical Status at BMT . | Interval Between Diagnosis and BMT (mo) . | Interval Between Last Remission and BMT (mo) . |
|---|---|---|---|---|---|---|
| 1 | 4 yr/F | + | VP16/ATG/Cs/CsA/IT MTX | CR | 24 | 1 |
| 2 | 2 mo/M | + | ATG/Cs/CsA/IT MTX | CR | 1 | 0.5 |
| 3 | 15 mo/M | − | VP16/Cs/CsA/IT MTX | CR | 10 | 1 |
| 4 | 1 yr/F | + | VP16/Cs/CsA/IT MTX | CR | 2 | 1.5 |
| 5 | 2 yr/M | − | VP16/Cs/CsA/IT MTX | CR | 2 | 1 |
| 6 | 13 mo/M | + | ATG/Cs/CsA/IT MTX | CR | 1 | 0.5 |
| 7 | 29 mo/M | + | ATG/Cs/CsA/IT MTX | CR | 3 | 2 |
| 8 | 7 mo/F | − | ATG/Cs/CsA/IT MTX | CR | 1 | 0.5 |
| 9 | 1 yr/F | − | VP16/Cs/CsA/IT MTX | CR | 2 | 1 |
| 10 | 2 yr/M | + | VP16/Cs/CsA/IT MTX | CR | 8 | 1 |
| 11 | 2 yr/M | + | VP16/ATG/Cs/CsA/IT MTX | CNS/low platelet count | 24 | 1 |
| 12 | 4 mo/M | − | ATG/Cs/CsA/IT MTX | HSM/low platelet count | 1 | 0.5 |
| 13 | 3 mo/M | + | ATG/Cs/CsA/IT MTX | HSM/CNS/low platelet count | 2 | 1 |
| 14 | 4 mo/F | − | ATG/Cs/CsA/IT MTX | HSM/low platelet count | 6 | 4 |
| Patient No. . | Age at Onset/Sex . | CNS Involvement . | Treatment Before BMT . | Clinical Status at BMT . | Interval Between Diagnosis and BMT (mo) . | Interval Between Last Remission and BMT (mo) . |
|---|---|---|---|---|---|---|
| 1 | 4 yr/F | + | VP16/ATG/Cs/CsA/IT MTX | CR | 24 | 1 |
| 2 | 2 mo/M | + | ATG/Cs/CsA/IT MTX | CR | 1 | 0.5 |
| 3 | 15 mo/M | − | VP16/Cs/CsA/IT MTX | CR | 10 | 1 |
| 4 | 1 yr/F | + | VP16/Cs/CsA/IT MTX | CR | 2 | 1.5 |
| 5 | 2 yr/M | − | VP16/Cs/CsA/IT MTX | CR | 2 | 1 |
| 6 | 13 mo/M | + | ATG/Cs/CsA/IT MTX | CR | 1 | 0.5 |
| 7 | 29 mo/M | + | ATG/Cs/CsA/IT MTX | CR | 3 | 2 |
| 8 | 7 mo/F | − | ATG/Cs/CsA/IT MTX | CR | 1 | 0.5 |
| 9 | 1 yr/F | − | VP16/Cs/CsA/IT MTX | CR | 2 | 1 |
| 10 | 2 yr/M | + | VP16/Cs/CsA/IT MTX | CR | 8 | 1 |
| 11 | 2 yr/M | + | VP16/ATG/Cs/CsA/IT MTX | CNS/low platelet count | 24 | 1 |
| 12 | 4 mo/M | − | ATG/Cs/CsA/IT MTX | HSM/low platelet count | 1 | 0.5 |
| 13 | 3 mo/M | + | ATG/Cs/CsA/IT MTX | HSM/CNS/low platelet count | 2 | 1 |
| 14 | 4 mo/F | − | ATG/Cs/CsA/IT MTX | HSM/low platelet count | 6 | 4 |
Abbreviations: HSM, hepatosplenomegaly; Cs, corticosteroids; IT MTX, intrathecal methotrexate; CsA, cyclosporine A; ATG, antithimoglobulins.